Estimate bleeding risk for patients on warfarin.
The ATRIA study was done to develop a risk stratification score to predict bleeding with warfarin.
The population studied had non-valvular, persistent atrial fibrillation
Major hemorrhage was defined as bleed that was fatal, required transfusion of ≥ 2 units blood, or hemorrhage into a critical anatomic site (intracranial, retroperitoneal, etc).
The following risk factors, along with their point value were determined as follows:
Risk of major hemorrhage was determined based on total score:
Studies that compared the performance of the ATRIA and HAS-BLED bleeding risk-prediction scores showed that HAS-BLED had better accuracy than ATRIA.
Fang MC, Go AS, Chang Y, et al.
Roldán V et al.
The ATRIA study was done to develop a risk stratification score to predict bleeding with warfarin.
The population studied had non-valvular, persistent atrial fibrillation
Major hemorrhage was defined as bleed that was fatal, required transfusion of ≥ 2 units blood, or hemorrhage into a critical anatomic site (intracranial, retroperitoneal, etc).
The following risk factors, along with their point value were determined as follows:
Risk of major hemorrhage was determined based on total score:
Studies that compared the performance of the ATRIA and HAS-BLED bleeding risk-prediction scores showed that HAS-BLED had better accuracy than ATRIA.
Fang MC, Go AS, Chang Y, et al.
Roldán V et al.
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.
